Activity of HMR3004 against Mycobacterium avium complex in vitro, in human macrophages and in beige mice
Open Access
- 1 June 1998
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 4 (6) , 325-331
- https://doi.org/10.1111/j.1469-0691.1998.tb00067.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prophylaxis against DisseminatedMycobacterium aviumComplex with Weekly Azithromycin, Daily Rifabutin, or BothNew England Journal of Medicine, 1996
- Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex DiseaseAnnals of Internal Medicine, 1994
- Efficacy of Rifabutin in the Treatment of Disseminated Infection Due to Mycobacterium avium ComplexClinical Infectious Diseases, 1994
- The Mycobacterium avium complexClinical Microbiology Reviews, 1993
- Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporineAntimicrobial Agents and Chemotherapy, 1993
- Treatment of Mycobacterium avium Complex Bacteremia in AIDS with a Four-Drug Oral RegimenAnnals of Internal Medicine, 1992
- Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDSThe Lancet, 1991
- Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- In vitro and in vivo activities of clarithromycin against Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 1989
- In Vitro and In Vivo Activity of Azithromycin (CP 62,993) Against the Mycobacterium avium ComplexThe Journal of Infectious Diseases, 1989